Abstract
IntroductionThe need for pharmacist-led antimicrobial stewardship programs (ASP) is increasing.ObjectiveWe performed a retrospective study to assess whether pharmacist-led ASPs can decrease the duration of treatment for uncomplicated gram-negative bacteremia among patients admitted in a community hospital.MethodsThis research was conducted at a 325-bed regional general hospital in Japan, from January 2013 to June 2015. There are no infectious diseases specialists affiliated with the hospital. The outcomes of the pharmacist-led ASP group, who received pharmacist intervention, and the control group, who did not receive pharmacist intervention, were compared. The study included patients aged 18 years or older who were diagnosed with gram-negative bacteremia. The pharmacist performed an antimicrobial time-out at 72 hours after blood culture collection and optimized treatment based on the patient's clinical response and test results. The primary outcome was the duration of antibiotic treatment. ResultsIn total, 34 patients in the pharmacist-led ASP group and 32 in the control group were included in the final analysis. The median number of days of antimicrobial treatment was 8 (interquartile range [IQR]: 7-14) days in the pharmacist-led ASP group and 14 (IQR: 10-15) days in the control group. The number of days of antimicrobial treatment significantly reduced in the pharmacist-led ASP group (p < 0.001). The de-escalation rates were 11 (32.4%) cases in the pharmacist-led ASP group and 4 (12.5%) cases in the control group. Hence, the trend was higher in the pharmacist-led ASP group than in the control group (p = 0.08).ConclusionThe pharmacist-led ASP reduced the number of days of antimicrobial therapy for uncomplicated gram-negative bacteremia among patients admitted in a community hospital without an infectious diseases specialist.
Highlights
The need for pharmacist-led antimicrobial stewardship programs (ASP) is increasing
34 patients in the pharmacist-led ASP group and 32 in the control group were included in the final analysis
The number of days of antimicrobial treatment significantly reduced in the pharmacist-led ASP group (p < 0.001)
Summary
This research was conducted at a 325-bed regional general hospital in Japan, from January 2013 to June 2015. The outcomes of the pharmacist-led ASP group, who received pharmacist intervention, and the control group, who did not receive pharmacist intervention, were compared. The study included patients aged 18 years or older who were diagnosed with gram-negative bacteremia. This study was conducted at National Hospital Organization Nishisaitama-Chuo National Hospital, a 325bed regional general hospital in Japan, from January 2013 to June 2015. The outcomes of the pharmacist-led ASP group, which received pharmacist intervention, and the control group, who did not receive pharmacist intervention and were management to usual treatment, were compared. The inclusion criterion included patients aged 18 years or older who were diagnosed with gram-negative bacteremia. The exclusion criteria were immunocompromised patients; those with sepsis, intravascular device, abscesses, carbapenem-resistant Enterobacteriaceae, and carbapenemase-producing Enterobacteriaceae; and those taking antimicrobials for less than 5 days or more than 21 days for suspected non-infectious or complicated bacteremia.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
